Oslo, Norway

Esben A Nilssen

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Esben A Nilssen: Innovator in Acoustically Sensitive Drug Delivery

Introduction

Esben A Nilssen is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on acoustically sensitive drug delivery particles. With a total of 3 patents, Nilssen's inventions are paving the way for advancements in targeted drug therapies.

Latest Patents

Nilssen's latest patents include groundbreaking technologies that utilize acoustically sensitive drug carrying particles. One of his patents focuses on particles comprising non-lamellar forming phosphatidylethanolamine. These novel particles are designed to accumulate in diseased target tissues and efficiently release their payload upon exposure to acoustic energy. Another patent highlights similar acoustically sensitive drug delivery particles, this time utilizing non-lamellar forming phosphatidylcholine. Both inventions aim to enhance the effectiveness of drug delivery in medical treatments.

Career Highlights

Throughout his career, Esben A Nilssen has worked with various companies, including Epitarget AS and Ic Targets AS. His experience in these organizations has contributed to his expertise in developing innovative drug delivery systems.

Collaborations

Some of his notable coworkers include Cecilia Leal Lauten and Sigrid L Fossheim. Their collaborative efforts have likely played a role in advancing Nilssen's research and development in the field.

Conclusion

Esben A Nilssen's work in acoustically sensitive drug delivery systems represents a significant advancement in medical technology. His innovative patents and collaborations continue to influence the future of targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…